DANIEL WILLIAM WOODFORD
Allopathic & Osteopathic Physicians|Internal Medicine BOWLING GREEN, VA NPI 1790761302
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine VA Novo Nordisk AS All categories
General Payments — all program years on this page
$1,014.92
- Category: General Payments
- Program years: PY2018–2024
- Record count: 52
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $158.69 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $158.69 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $45.00 | 3 |
| Abbott Laboratories | $42.74 | 2 |
| Otsuka America Pharmaceutical, Inc. | $40.03 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $30.92 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092343462 | Boston Scientific Corporation | $30.92 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097215049 | Novo Nordisk Inc | $16.57 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097245900 | Novo Nordisk Inc | $13.51 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097526190 | Novo Nordisk Inc | $14.92 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119006357 | Otsuka America Pharmaceutical, Inc. | $21.81 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1119006359 | Otsuka America Pharmaceutical, Inc. | $18.22 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125275646 | Abbott Laboratories | $20.89 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1125275648 | Abbott Laboratories | $21.85 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.